Pattern of use of β-blockers in older patients with stable coronary artery disease: An observational, cross-sectional, multicentre survey

Drugs and Aging

Volumn 28, Issue 9, 2011, Pages 703-711

  Vitale, Cristiana ^a   Spoletini, Ilaria ^a   Volterrani, Maurizio ^a   Iellamo, Ferdinando ^a,b   Fini, Massimo ^a  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Beta adrenergic receptor antagonists; Coronary artery disease; Drug utilisation; Elderly; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG USE; DRUG UTILIZATION; FEMALE; HEALTH SURVEY; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED;

EID: 80052844290     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11594220-000000000-00000     Document Type: Article

References (31)

1. Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J AmColl Cardiol 2007 Aug; 50 (9): 823-30 (Pubitemid 47277500)
2. Palatini P. Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms. Drugs 2007; 67 Suppl. 2: 3-13 (Pubitemid 350114591)
3. Cucherat M. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in postmyocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J 2007 Dec; 28 (24): 3012-9 (Pubitemid 350262265)
4. Aronow WS. Postinfarction use of beta-blockers in elderly patients. Drugs Aging 1997; 11 (6): 424-32 (Pubitemid 27524938)
5. Alexander KP, Peterson ED. Treatment of non-ST-elevation acute coronary syndrome in the elderly: current practice and future opportunities. Am J Geriatr Cardiol 2006 Jan- Feb; 15 (1): 42-9
6. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008 Oct; 29 (19): 2388-442
7. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008 Dec; 29 (23): 2909-45
8. Gurwitz JH, Goldberg RJ, Chen Z, et al. Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med 1992 Dec; 93 (6): 605-10
9. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 1996 Apr; 156 (7): 799-805 (Pubitemid 26108203)
10. Vitale C, Iellamo F, VolterraniM, et al. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: analysis of the CARDIf study cohort. Angiology 2010 Nov; 61 (8): 763-7
11. Austin PC, Tu JV, Ko DT, et al. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction. CMAJ 2008 Oct; 179 (9): 895-900
12. Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure: a Bayesian meta-analysis. Ann Intern Med 2001 Apr 3; 134 (7): 550-60 (Pubitemid 32245316)
13. Gottlieb SS, McCarter RJ, Vogel RA. Effect of betablockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998 Aug 20; 339 (8): 489-97 (Pubitemid 28384881)
14. Heller DA, Ahern FM, Kozak M. Changes in rates of betablocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction. Am Heart J 2000 Oct; 140 (4): 663-71
15. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998 Aug; 280 (7): 623-9
16. Schiele F, Meneveau N, Seronde MF, et al. Changes in management of elderly patients with myocardial infarction. Eur Heart J 2009 Apr; 30 (8): 987-94
17. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997 Jan; 277 (2): 115-21 (Pubitemid 27030178)
18. Di Chiara A, Chiarella F, Savonitto S, et al. Epidemiology of acute myocardial infarction in the Italian CCU network: the BLITZ study. Eur Heart J 2003 Sep; 24 (18): 1616-29 (Pubitemid 37174901)
19. Di Chiara A, Fresco C, Savonitto S, et al. Epidemiology of non-ST elevation acute coronary syndromes in the Italian cardiology network: the BLITZ-2 study. Eur Heart J 2006 Feb; 27 (4): 393-405 (Pubitemid 43209162)
20. Filippi A, DAmbrosio G, Giustini SE, et al. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care. J Cardiovasc Med (Hagerstown) 2009 Sep; 10 (9): 714-8
21. Dudley NJ, Bowling A, Bond M, et al. Age- and sex-related bias in the management of heart disease in a district general hospital. Age Ageing 2002 Jan; 31 (1): 37-42 (Pubitemid 34187750)
22. Gheorghiade M, Filippatos G. Reassessing treatment of acute heart failure syndromes: the ADHERE Registry. Eur Heart J Suppl 2005; 7 (Suppl. B): B13-9 (Pubitemid 40516891)
23. Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, et al. Characteristics and outcomes of patients with heart failure in general practices and hospitals. Circ J 2007 Apr; 71 (4): 449-54
24. Maggioni AP, Dahlström U, Filippatos G, et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2010; 12 (10): 1076-84
25. Komajda M, Hanon O, Hochadel M, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Heart J 2009 Feb; 30 (4): 478-86
26. Bowling A. Ageism in cardiology. BMJ 1999 Nov 20; 319 (7221): 1353-5 (Pubitemid 29537510)
27. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002 Aug; 162 (15): 1682-8
28. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007 Jul; 370 (9582): 185-91 (Pubitemid 47042897)
29. Hernandez AF, Hammill BG, OConnor CM, et al. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol 2009 Jan; 53 (2): 184-92
30. Böhm M, Swedberg K, Komajda M, et al., SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010 Sep 11; 376 (9744): 886-94
31. Aronow WS, Ahn C, Mercando AD, et al. Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 1996 Nov; 78 (10): 1175-6 (Pubitemid 126657187)